1141929

Pine Pharmaceuticals, LLC — FEI 3010943533

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
May 14, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Tonawanda, NY (United States)

Citations

IDCFRDescription
109821 CFR 211.22(c)Approve or reject procedures or specs
126121 CFR 211.68(a)Written calibration / inspection records not kept
145121 CFR 211.113(b)Procedures for sterile drug products
202721 CFR 211.192Investigations of discrepancies, failures
360321 CFR 211.160(b)Scientifically sound laboratory controls